ASCO 2023

American Society of Clinical Oncology

June 2-6, 2023

This year's meeting will be in-person in Chicago and online.

The American Society of Clinical Oncology (ASCO) annual meeting offers premier scientific events for oncology professionals, patient advocates, industry representatives and major media outlets worldwide.

The 2023 ASCO annual meeting, held in Chicago, provides an opportunity to learn about the latest developments in cancer science from Fred Hutchinson Cancer Center and research institutions around the world. The program features more than 200 sessions complementing the meeting’s theme: Partnering with Patients - The Cornerstone of Cancer Care and Research.

Follow Fred Hutch at ASCO: #ASCO23 |  Facebook  |  Twitter

Date:
Friday-Tuesday, June 02-06, 2023
Host or Sponsor:
American Society of Clinical Oncology
Location:
Chicago, Illinois
Contact Information:
Visit us at the Conference:
Fred Hutch Booth: 4023

Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance have merged to form Fred Hutchinson Cancer Center, a unified adult cancer research and care center that brings together SCCA and Fred Hutchinson Cancer Research Center into a single, independent, nonprofit organization that is also a clinically integrated part of UW Medicine and UW Medicine’s cancer program. 

Highlights of Fred Hutch Presentations at ASCO

Oral Abstract  |  Poster Discussion Session  |  Poster Session  |  Publication Only

Oral Abstract

Oral Abstract: Risk of early mortality in patients with cancer experiencing adverse financial events.
Presenter: Hiba Khan
Tuesday, June 6, 9:00 a.m. - 9:12 a.m. (CT)

Poster Discussion Session

Poster Discussion Session: Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.
Presenter: Emily Liang
Monday, June 5, 1:15 p.m. - 2:45 p.m. (CT)

Poster Discussion Session: The impact of adverse financial events on healthcare utilization and treatment costs at the end of life.
Presenter: Chipo Kwendakwema
Saturday, June 3, 4:30 p.m. - 6:00 p.m. (CT)

Poster Session

Poster Session: Preclinical testing of FOLR1-CAR T cells against osteosarcoma (OS).
Presenter: Michelle Choe
Saturday, June 3, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.
Presenter: Carrie Ho
Monday, June 5, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: Evaluation of cardiac failure and recovery in acute myelogenous leukemia.
Presenter: Matthew Wu
Monday, June 5, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: The somatic mutation profile of breast cancer in Uganda.
Presenter: Manoj Menon
Sunday, June 4, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: PSMA expression and response to 177Lu-PSMA-617 (LuPSMA) in men with vs. without DNA damage repair (DDR) mutations.
Presenter: Ruben Raychaudhuri
Saturday, June 3, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma.
Presenter: Laura Samples
Monday, June 5, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: Impact of COVID-19 pandemic mitigation strategies on industry and NCI cancer treatment trials.
Presenter: Joseph Unger
Monday, June 5, 1:15 p.m. - 4:15 p.m. (CT)

Poster Session: Preclinical evaluation of targeting PRAME with TCR mimic CAR T cells in AML.
Presenter: Danielle Kirkey
Saturday, June 3, 8:00 a.m. - 11:00 a.m. (CT)

Poster Session: Use of germline testing in patients with prostate, pancreatic, or ovarian cancer in Washington (WA) state.
Presenter: Veena Shankaran, Qin Sun
Saturday, June 3, 1:15 p.m. - 4:15 p.m. (CT)

Poster Session: Outcomes with immune checkpoint inhibitors (ICI) in patients (pts) with MTAP alterations (alt) in advanced urothelial carcinoma (aUC).
Presenter: Rafee Talukder
Saturday, June 3, 8:00 a.m. - 11:00 a.m. (CT)

Publication Only

Latest ASCO News

All news
ASCO 2022: Equity, innovation and in-person Hutch cancer researchers, clinicians share findings on clinical trial eligibility, Medicaid expansion, wearables to track symptoms and more June 9, 2022
Cancer clinical trials exclude too many patients: That’s changing Calls for equity, inclusion and better access boost pre-pandemic efforts to open up eligibility, streamline trials August 11, 2021
ASCO 2023 highlights: Fine-tuning cancer care Annual oncology meeting emphasizes less-toxic treatments, more precision oncology and new ways to reduce collateral damage June 9, 2023

Contact Media Relations

Claire Hudson

Heather Platisha